Alterations of Hemostatic Molecular Markers During Acute Large Vessel Occlusion Stroke
Open Access
- 6 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (3) , e032651
Abstract
Background: This study aimed to investigate regional levels of TAT (thrombin‐antithrombin complex), PIC (plasmin‐α2 plasmin inhibitor complex), t‐PAIC (tissue plasminogen activator‐plasminogen activator inhibitor complex), sTM (soluble thrombomodulin), and D‐dimer, along with their associations with clinical and procedural characteristics in patients with acute ischemic stroke undergoing endovascular thrombectomy. Methods and Results: We retrospectively analyzed 166 consecutive patients with acute ischemic stroke (62±11.54 years of age, 34.3% women) using prospectively maintained clinical databases and blood samples from local ischemic (proximal to thrombus) and systemic (femoral artery, self‐control) arterial compartments. Levels of TAT, PIC, t‐PAIC, and D‐dimer were significantly elevated, whereas sTM was significantly reduced, in local ischemic regions compared with their systemic levels. Each 1‐unit increase in ischemic TAT (adjusted odds ratio [aOR], 1.086 [95% CI, 1.03–1.145]; P =0.002; area under the curve [AUC], 0.833) and PIC (aOR, 1.337 [95% CI, 1.087–1.644]; P =0.006; AUC, 0.771) correlated significantly with higher symptomatic intracranial hemorrhage risk. Additionally, each 1‐unit increase in ischemic TAT (aOR, 1.076 [95% CI, 1.016–1.139]; P =0.013; AUC, 0.797), PIC (aOR, 1.554 [95% CI, 1.194–2.022]; P =0.001; AUC, 0.798), and sTM (aOR, 0.769 [95% CI, 0.615–0.961]; P =0.021; AUC, 0.756) was significantly associated with an increased risk of an unfavorable 90‐day outcome (modified Rankin scale of 3–6). These hemostatic molecules, individually or combined, significantly improved the predictive power of conventional risk factors, as evidenced by significant increases in net reclassification improvement and integrated discrimination improvement (all P <0.01). Conclusions: We observed a hyperactive state of the coagulation‐fibrinolysis system within the local ischemic region during hyperacute stroke. Rapid automated measurement of hemostatic molecular markers, particularly TAT, PIC, and sTM, during intra‐arterial procedures may provide additional information for stroke risk stratification and therapeutic decision‐making, and warrants further investigation.Keywords
This publication has 47 references indexed in Scilit:
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaborationInternational Journal of Surgery, 2014
- Statistical methods for assessment of added usefulness of new biomarkersClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PAThrombosis and Haemostasis, 2009
- Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic StrokeStroke, 2006
- Tissue Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex as Risk Factors for the Development of a First StrokeStroke, 2000
- Alterations of Platelet, Coagulation, and Fibrinolysis Markers in Patients with Acute Ischemic StrokeSeminars in Thrombosis and Hemostasis, 1997
- Detection of prothrombotic state in ischemic stroke by monitoring plasma molecular markersJournal of Stroke and Cerebrovascular Diseases, 1994
- Alterations of haemostatic markers in various subtypes and phases of strokeBlood Coagulation & Fibrinolysis, 1993
- Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients.Stroke, 1991
- Activation of coagulation in acute cardioembolic stroke.Stroke, 1991